Area of research
Molecular Biology · Hepatology
Research interest
Research focused on Downregulation and upregulation and Ex vivo, with related work in Risk analysis (engineering), Angiogenesis, Apolipoprotein B. Notable publications include 'FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2', 'Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies', and 'PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression'.
Successful AAV8 gene therapy on hepatic ex situ machine perfusion for mitochondrial neurogastrointestinal encephalomyopathy
A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression
Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies